Summarised appraisal of TB and DM guidelines and policy-related documents for research & evaluation II (AGREE) - AGREE II Documents Review Approach | |||||||||
No: | Document Title | Scope and Purpose | Stakeholders Involvement | Rigour of Development | Clarity of Presentation | Applicability | Editorial Independence | Aggregate Score | Overall Score (%) |
1 | National Action Plan for Prevention and Management of non-communicable diseases in Malawi (2012–2016) (2013) | 19 | 15 | 10 | 20 | 15 | 13 | 92 | 70.4 |
2 | Health Sector Strategic Plan II 2017–2022. (2017) | 19 | 16 | 17 | 20 | 17 | 16 | 105 | 80.6 |
3 | The Malawi Non-communicable Diseases and Injuries Poverty Commission Report: Reframing Non-communicable Diseases and Injuries for the Poorest Billions (2018) | 19 | 18 | 16 | 20 | 16 | 15 | 104 | 79.6 |
4 | National laboratory policy “Comprehensive, Accessible, Affordable and Quality Services to all” (2017) | 18 | 15 | 11 | 18 | 15 | 13 | 90 | 66.7 |
5 | Malawi National Tuberculosis Control Programme Manual42 | 18 | 16 | 11 | 19 | 17 | 17 | 98 | 74.1 |
6 | Tuberculosis Control Programme National Strategic Plan 2015–2020 (2015) | 19 | 18 | 14 | 20 | 20 | 16 | 107 | 82.4 |
7 | Guidelines for Infection Prevention and control for Tuberculosis (2016) | 18 | 18 | 13 | 19 | 17 | 15 | 100 | 75.9 |
Maximum possible score = Strongest agree(7), domains(6), appraisers(3) = 126; minimum possible score = strongest strongly disagree(1), domains(6), appraisers(3) = 18. Appraisers’ coring Rates used per domain: 1, 2, 3, 4, 5, 6, 7, where 1 is strongly disagree and 7 is strongly agree as adopted from AGREE approach, the scaled domains % score will be: (obtained score − minimum score)/(maximum possible score − minimum possible score).(23)
Assessment summary of scoring of implementation plans and guidelines documents on development process and contents in related to TB and DM services delivery and management of both diseases in Malawi through application of AGREE II approach.
AGREII, Appraisal of Guidelines for Research and Evaluation II; DM, diabetes mellitus; TB, tuberculosis.